CardioLogs ECG Analysis Platform vs ZEUS System

Direct competitors — feature-level head-to-head below. Comparability 85/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Cardiologs Technologies (now part of Philips)
VS
by iRhythm Technologies

AI Verdict

The Cardiologs ECG Analysis Platform and the ZEUS System are direct competitors, both utilizing AI for ECG data analysis to detect and diagnose arrhythmias. While Cardiologs emphasizes broad multi-device compatibility and rapid analysis, the ZEUS System is specifically tailored for long-term continuous monitoring, integrating with iRhythm's proprietary wearable biosensors. The optimal choice depends on the desired integration with existing monitoring devices and the specific duration of cardiac monitoring required.

Choose CardioLogs ECG Analysis Platform if…

Choose CardioLogs ECG Analysis Platform if your practice utilizes a diverse range of cardiac monitoring devices, including Holter, smartwatches, and various ECG patches, and requires a flexible, centralized AI platform for rapid and accurate analysis of all incoming ECG data. This solution is ideal for consolidating analysis workflows and generating customizable reports across multiple device types.

View CardioLogs ECG Analysis Platform →

Choose ZEUS System if…

Choose the ZEUS System if your primary focus is on long-term continuous cardiac monitoring, especially when integrating with iRhythm's Zio wearable biosensors for extended periods (up to 14 days). This system is optimized for comprehensive arrhythmia detection, particularly Atrial Fibrillation, through an integrated wearable and cloud-based analytics approach.

View ZEUS System →

When choosing between the CardioLogs ECG Analysis Platform and the ZEUS System, physicians should consider their primary need for ECG analysis. CardioLogs, now a Philips solution, excels in providing rapid, accurate, and efficient analysis of ECG data from a variety of cardiac monitoring devices, including Holter monitors, smartwatches, and ECG patches. Its medical-grade AI, powered by deep neural networks, is designed for automated arrhythmia detection and offers customizable reports and EHR integration. This platform is best suited for practices that utilize diverse ECG acquisition methods and require a flexible, cloud-based solution for quick turnaround on arrhythmia diagnoses.

In contrast, the ZEUS System by iRhythm Technologies focuses on AI-powered analysis of ECG data specifically from its wearable biosensors for long-term continuous cardiac monitoring, up to 14 days. While both systems are cloud-based and HIPAA compliant with FDA clearance, the key practical difference lies in their data input. CardioLogs offers multi-device compatibility, making it adaptable to existing workflows with various ECG devices. ZEUS, however, is integrated with iRhythm’s Zio Watch and Zio monitors, making it ideal for practices prioritizing extended, continuous monitoring with a dedicated, integrated wearable solution. Physicians whose practice heavily relies on long-term, continuous monitoring with iRhythm’s proprietary devices would find ZEUS more aligned with their needs.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CardioLogs ECG Analysis Platform ZEUS System
Pricing Contact sales for customized quote Not disclosed
Deployment Cloud-based (SaaS) Cloud-based (AWS EC2 platform), no on-premise hardware.
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ZEUS System

Tool B offers a comprehensive patient and provider experience with its ZioSuite portal and MyZio app, designed for ease of use and high patient compliance with its wearable monitor. While Tool A emphasizes efficient analysis and a user-friendly interface for clinicians, Tool B's integrated approach across the entire monitoring journey gives it an edge in overall usability.

Clinical Value

ZEUS System

While both tools demonstrate strong clinical accuracy and FDA clearance, Tool B's extensive body of evidence highlights superior diagnostic yield, reduced retesting, and a lower likelihood of cardiovascular events compared to other long-term continuous monitoring services. This focus on improved patient outcomes and reduced healthcare utilization, combined with 99% physician agreement on its reports, gives it a slight edge in overall clinical value.

Pricing & Value

CardioLogs ECG Analysis Platform

Tool A offers a transparent pricing model of 'pay per ECG,' which provides clarity on how costs are incurred, even if specific rates require contacting sales. In contrast, Tool B's pricing is not disclosed, making it difficult to assess its direct cost-effectiveness, although it does offer patient financial assistance programs.

Enterprise Readiness

CardioLogs ECG Analysis Platform

Both tools are cloud-based, FDA-cleared, HIPAA compliant, and offer EHR integration, demonstrating strong foundational enterprise readiness. However, Tool A's integration with the Philips IntelliBridge Enterprise solution specifically highlights its capability for deeper and more comprehensive integration within large, complex healthcare systems, giving it a slight advantage.

Innovation

Tie

Both tools demonstrate significant innovation in applying AI to cardiac diagnostics. Tool A was a pioneer as the first FDA-cleared AI for ECG analysis and boasts device-agnostic compatibility and predictive capabilities for AFib. Tool B, with its proprietary Zio wearable monitors and specialized AI algorithms optimized for long-term, continuous, and battery-constrained monitoring, offers a complete and patient-centric innovative solution.

Support & Docs

Tie

Both companies provide comprehensive support channels and documentation. Tool A, as a Philips solution, offers a robust support center, product manuals, and training, with mentions of 24/7 customer support. Tool B explicitly highlights 24/7 phone and email support for both patients and providers, along with clinical reference manuals.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CardioLogs ECG Analysis Platform ZEUS System
Company Cardiologs Technologies (now part of Philips) iRhythm Technologies
Tagline Reinventing cardiology diagnostics with medical-grade AI and cloud technology. AI-powered cardiac monitoring for early arrhythmia detection and management.
Key Feature: AI-Powered Arrhythmia Detection AI-Powered ECG Analysis (Deep Neural Networks), Automated Arrhythmia Detection (e.g., AFib, VT) AI-powered arrhythmia detection, Detection and characterization of Atrial Fibrillation (AFib)
Key Feature: Multi-Device Compatibility Multi-Device Compatibility (Holter, smartwatches, ECG patches) Integration with Zio Watch and Zio monitors

Videos

Demos, reviews, and walkthroughs featuring CardioLogs ECG Analysis Platform and ZEUS System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The CardioLogs ECG Analysis Platform offers multi-device compatibility, supporting ECG data from various cardiac monitoring devices such as Holter monitors, smartwatches, and ECG patches. In contrast, the ZEUS System is designed to analyze ECG data specifically from iRhythm's wearable biosensors, including Zio Watch and Zio monitors.
The CardioLogs platform provides real-time monitoring and analysis of ECG data. The ZEUS System is specifically built for long-term continuous cardiac monitoring, capable of analyzing ECG data for up to 14 days from its compatible wearable biosensors.
The CardioLogs ECG Analysis Platform is capable of automated arrhythmia detection for various conditions, including Atrial Fibrillation (AFib) and Ventricular Tachycardia (VT). The ZEUS System primarily focuses on the detection and characterization of arrhythmias like Atrial Fibrillation and supports both symptomatic and asymptomatic cardiac events.
The CardioLogs ECG Analysis Platform provides customizable reports for physicians, allowing for tailored presentation of analysis. The ZEUS System generates preliminary reports for physicians, aiding in the diagnosis and management of arrhythmias.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.